Morepen Laboratories vs Peers
- Market cap
- ₹7,216 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹94.82 – ₹177.78
Morepen Laboratories ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Morepen Laboratories. Its P/E of 22.5 compares with a peer median of 22.5.
Morepen Laboratories vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Morepen Laboratories | 131.69 | -3.56% | 7,216 | 22.5 | 2.85 | 14.5% | +18.5% |
| Morepen Laboratories | 131.69 | -3.56% | 7,216 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Morepen Laboratories peer comparison — frequently asked questions
Who are Morepen Laboratories' competitors?
Morepen Laboratories' listed peers in Drug Manufacturers - Specialty & Generic include Morepen Laboratories, ranked here by market capitalisation.
How does Morepen Laboratories' P/E compare with its peers?
Morepen Laboratories trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Morepen Laboratories' peers?
By market capitalisation, the largest company in the group is Morepen Laboratories at ₹7,216 crore, against ₹7,216 crore for Morepen Laboratories.
Same Data For Peers
Trade Morepen Laboratories With ATS
Track MOREPENLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.